Cardiology With M. Andrew Morse, MD, FSCAI

Cardiology

Dr. Morse is currently the chief of interventional cardiology and director of valvular and structural heart disease at Ascension Saint Thomas Hospital West in Nashville, Tennessee. He completed his training at Emory and Northwestern Universities, is active in medical device research, and is a member of several national trial steering committees.

  • M. Andrew Morse, MD, FSCAI,
    Cardiology

    Dear Readers, Despite the controversial history of routine aspiration thrombectomy in acute myocardial infarction (MI), the technology and techniques continue to evolve. The body of…

  • M. Andrew Morse, MD, FSCAI,
    Cardiology

    Dear readers, There was no shortage this year (#ACC23) of interesting data around athletes with inheritable heart conditions. Recent events (including Damar Hamlin) of athletes…

  • M. Andrew Morse, MD, FSCAI,
    Cardiology

    Dear readers, As day 2 of #ACC23 kicks off the agenda is packed with interesting scientific presentations. The TRILUMINATE pivotal trial results were delivered yesterday…

  • M. Andrew Morse, MD, FSCAI,
    Cardiology
    - 2 year(s) ago

    Transcatheter aortic valve replacement (TAVR) is a mainstream therapeutic option for patients with severe aortic stenosis at over 700 sites in the US. Despite having…

  • M. Andrew Morse, MD, FSCAI,
    Cardiology
    - 2 year(s) ago

    Transcatheter edge to edge repair (TEER) was a hot topic at #TCT2022 today. Release of the pivotal CLASP IID Trial data comparing the Pascal and…

  • M. Andrew Morse, MD, FSCAI,
    Cardiology
    - 2 year(s) ago

    Exciting start to #TCT2022 in Boston. Several long awaited late breaking clinical trials to come over the next few days that will impact the way…